Jan 7, 2025
On this episode of The Founder's Sandbox, Brenda speaks with Jane Zhang, CEO and Founder of Remmie Health about Scalable AI in Pediatrics. Jane progressed through her professional career as Biomedical Engineer, PhD Adjunct Professor, Big Pharma and it was upon living a very personal situation that she wanted be become a “builder": entrepreneurship was calling her.
Listen to Jane’s podcast, as she shares where this whole idea of building something for the people at home to be able to examine, share, and, in the future - get assistance in identifying ENT diseases- became very important to her. Jane shares how she has built a product and services for at home examinations of the ear, nose, and throat and her real experience of developing a FDA approved Class 1 device, now in clinical trials.
Remmie 3 is a FDA-registered and CE Marked next generation intelligent otoscope designed for patients of all ages.
You can find out more about Jane and Remmie Health at:
https://www.linkedin.com/in/janeyzhang
https://www.linkedin.com/company/remmiehealth/
Remmie was present at MEDICA 2024, the most important international fair dedicated to medicine and hospital technology. The event will took place in Düsseldorf, Germany, from 11 to 14 November 2024.
https://www.ca-mi.eu/en/germany/01/2024/medica-dusseldorf-11-14-november-2024/
and at the American Speech-Language-Hearing Association 2024 ASHA Convention from December 5-7 in Seattle, Washington.
Transcript:
00:04
Hi, I'm pleased to announce something very special to me, a new
subscription-based service through Next Act Advisors that allows
members exclusive access to personal industry insights and
bespoke
00:32
corporate governance knowledge. This comes in the form of blogs,
personal book recommendations, and early access to the founder's
sandbox podcast episodes before they released to the public. If you
want more white glove information on building your startup with
information like what was in today's episode, sign up with the link
in the show notes to enjoy being a special member of Next Act
Advisors.
01:01
As a thank you to Founders Sandbox listeners, you can use code
SANDBOX25 at checkout to enjoy 25% off your membership costs. Thank
you.
01:18
Welcome back to the Founders Sandbox. I am Brenda McCabe, your
host. This is a monthly podcast in which I reach entrepreneurs,
business owners, and I have as my guest, entrepreneurs and business
owners, professional service providers, and corporate board
directors who bring their own stories about building resilient,
purpose-driven, and sustainable businesses with great corporate
governance.
01:47
I want to assist entrepreneurs and entrepreneurs in building those
scalable, well-governed and resilient businesses. And by bringing
my guests to the podcast, they too want to use the power of the
enterprise, small, medium and large to create change for a better
world. We're going to tell stories in this podcast today. And my
guest is Jane Zhang. She's CEO of Remmie and she's joining us here
from the state of Washington.
02:17
Jane and I go back almost, I don't know, four or five years now.
Jane was at the UCLA MedTech competition. She had just founded
Remmie in 2018 and then actually put some bones around it and
financing into 2020 was actually seeking external investment
dilutive type. And I couldn't help.
02:46
but remember Jane's origin story of why she started Remmie. And
we're gonna start with that. So Jane, I would love for you to walk
down memory lane with me and go back to when we met in the campus
at the UCLA MedTech. And what was your origin story? Yeah, Brenda,
I really appreciate this opportunity and thank you for the great
intro. It was.
03:14
It was unforgettable why I, every day I'm reminded of why I'm on
this mission because my own son, who was a preschooler back then,
had recurring ear, nose and throat issues, especially ear
infections. It was basically nonstop. A lot of the weekends, my
colleagues would ask me, what are you doing on the weekend? I'd be
like,
03:43
My son is having a fever I'm taking next week off. So it happened
four times. In the first year he went to childcare. And one of the
times he had a high fever, we went to the ER and it took us four
hours sitting there nonstop with his crying and screaming. And the
other times we were referred to an ENT specialist who was about to
put in ear tubes in his ears. And other times we were
04:12
misdiagnosed because he had air nose and hands with mouse disease
where we were given antibiotics. I give him 10 days and he's still
spiking a fever. It keeps on coming back. And the doctor said there
was a it was a moment of revelation where this physician, my
pediatrician told me, come, come take a look by yourself. I was
like, what? Why? And he said the throat or the back of his throat
was all white blisters. So this was not an air infection.
04:43
um who gave you antibiotics that was the question he asked me he
said you should be able to look by yourself and why weren't you
doing that i was like what really i'm a bio medical engineer by
training by the way um especially in low resource setting
diagnostics or like basically home home diagnostic kits um he asked
me why aren't you looking by yourself i was like what am i supposed
to look uh and with what
05:11
So that's where this whole idea of building something for the
people at home to be able to examine, share, and in the future
getting assistance in identifying ENT diseases became very
important to me. Wow. So you had at that time been working
05:36
for a large pharmaceutical company. As you said, you are a
biomedical engineer by training, and you just completed your
executive MBA, I think at UCLA. So what made you make the jump? One
thing is going to the emergency room with your child time and time
again. You talked about your aha moment and how can I in a low
resource, right? At home.
06:03
be able to actually diagnose and actually treat my child. What
happened that made you want to actually become an entrepreneur,
Jane? One thing is working on the research side, but becoming an
entrepreneur, what made you do that? It was very, so it was like
everything kind of lined up in a way, and it just, my background, I
was an engineer by training.
06:32
I worked as a scientist, you know, like in all the way up to
postdoctoral level research. And then I took a turn into getting
more into product development, business development, and commercial
operations, because I thought that was really going to help me
broaden my vision of the my view of how things work, you know, that
I'm basically a curiosity driven person.
06:57
And at that point, while I was working in a big corporate, in a
pharmaceutical company, I was sort of getting more experienced in a
commercial side of things. I figured I had two choices, probably
one, two, actually three choices I was considering, right? Like one
is to go back to research and become a faculty member. In fact, I
did, you know, that was kind of my way of rethinking my whole,
reorienting my whole career path.
07:25
Um, the other one was going to become an investor. Um, the third
was to fund my own company and just go on this path of building
things. Um, I, I thought, uh, this issue of my child's problem just
really was hitting at home that this is, because it's after I
talked to many people, I was not alone. I'm not the only person
who's going through this. Everyone I talked to said, Oh my gosh,
that was me. Um,
07:54
I was like, this is a big deal. It not only impacts your child's
health, it impacts your productivity at the prime time of your life
when you just had the child. And it was just like really hitting a
home. I had to do this after a couple of years of hiatus in
academics, in academia, as a faculty member of engineering in
University of Washington. After completing my MBA, in the meantime,
I decided being a builder.
08:24
an entrepreneur is the calling for me. Is the path, is the path to
shift. Amazing. Talk to me about the number of ENT cases that you
are addressing with Remy today. Talk to me about that. I guess a
striking number was 70 million in the US, both adults and children.
A year, right? And it's really fast. A year. Yeah.
08:53
suffering from some ENT diseases. And this is not just specialty
disease that I'm talking about, it's every day. Like anything that
you have when you have a sore throat, a painful nose or ear
infection or cold and flu, it impacts these organs. The first line
organs being impacted are your ENT, but it doesn't stop there,
right? For children, it is very highly occurring. Like if you look
at the number of children who go see ENT issues, ear infections
alone is...
09:22
about 24 million a year, that's 80% of any children before the age
of eight or three, they've already had one ear infection, not to
mention 30% have more than three a year. And adults, like when
you're thinking about, sinusitis, sore throat, strapped throat, how
all these impact the overall population quite a bit. So what is the
solution at that?
09:50
Remy provides. You're going to walk us through kind of the, it's AI
powered ENT, so ear, nose and throat health platform. It has many
components. What's the patient experience today that you're
attacking and how is it going to look in the future? Walk us
through the product, please. Yeah. I love that way of thinking and
thinking as a patient or a user of any anything that we are
providing.
10:20
So you already kind of heard my journey of nonstop sort of rotation
in like a spinning wheel among pediatrics office, urgent care,
ENT's office, and ER, right? And then over again for another
episode, if it's recurring or chronic. The experience that we're
trying to provide is along the line of how the disease progresses
and how physicians examine.
10:50
a quadrant or like a progression lifetime along that line. What I
mean is when you first have a pain or some sort of discomfort, you
would want to, you know, a doctor when they examine you, they would
check, they would look, they would look with a, right now they look
with an otoscope, which is a glorified flashlight plus magnifier,
obviously very, very high fidelity.
11:20
That's the first step. They look, they examine. And then the second
thing they do is, well, obviously you have to be in person first
with the physician, right? So there's no sharing per se, which
we're trying to build towards is you can look, you know, if a
doctor is using an otoscope, why can't the patient be taught how to
use it? It's very similar to a thermometer in a way, except it's a
camera. So, you know, if a physician is looking with their eye.
11:48
we can make it digitized as a camera for patients to use at home.
And if you have to be in person today, you should be able to
transmit this, whatever you're looking at or collecting over the
internet in terms of sharing. And then the third step of the whole
diagnosis journey is basically analyze. The physician kind of asks
you how you feel, they aggregate a lot of information about you,
who you are, what you're going through and your physical
presentation of the symptoms.
12:19
that should also be partly supported by AI. So that's kind of what
I'm working towards is, it's like a million doctors supporting
every single physician, every, you know, one doctor being supported
by a million in terms of the insights that's used to go into their
diagnosis. And did I mention that the misdiagnosis rate is about
40% on any day? Misdiagnosis meaning either, you know,
12:49
you're prescribed antibiotics where you're not, you should not have
been, or you're referred to a specialist where you should not have
been, or you went to the ER, because you did not receive the care
in time. I guess that's a broader sense of misdiagnosis, which
means you missed the opportunity for diagnosis in the proper
setting. So, but that's very prevalent in terms of misdiagnosis. So
we like to support anyone who's
13:17
first examining the condition with AI tools, being a patient or a
primary care physician. Before we get into the AI question that I
have for you, talk to me about some of the communities that can
benefit from the use of an AI-powered ENT device. Yeah. I.
13:46
The first thing that comes to my mind is home users, any general
lay person at home who may not have the resources to see a
physician in person. It could be someone who's lack of access in a
way that they are in a remote area, lack of resources to pay for
healthcare, or even lack of time. Someone who is working, who has a
job but just doesn't have the time to.
14:15
to see a doctor. So I would think under underserved communities,
population who are at lack of resources such as time, money, or you
know, driving. You know, driving is a hassle for a lot of families
and just anywhere at home. Anyone who is, you know, even I was
talking to a bunch of undergrad, you know, college students are
like, we're so used to just sitting on our couch and see a
doctor.
14:45
That's possible. And that was really the key moment when I was
sitting as a judge. The first time I actually was exposed to you,
Jane, met you and heard about Remy, it was the possibility that
digital health, right? I'm not having to go into a doctor's office.
And the digital health to use preventatively, right? To prevent
disease.
15:13
diseases to progress. I think, and then, you know, AI is just an
added layer on top, so that truly was a moment when I thought
everybody, well, at least there's 70 million cases a year of ear,
nose, and throat, what this platform may offer for other disease
areas where we don't have necessarily to go into the doctor's
office. So it was fascinating. That's what brought us into this
relationship.
15:41
So talk to me about, we've talked about the platform, where you're
going, how it's offered. What has been your founder experience? All
right, you decided you took a head issue and went back to the
academic world. You really wanted to become an entrepreneur,
started the company. You won a competition out of UCLA, I think
business case. That's about the time I met you, right? Talk to me
about how the journey has been in terms of
16:10
resources, the resources that you have received, non-dilutive
funding, where are you on that path, and how many healthcare
systems are currently either testing or looking into the use of
Remy? That's a loaded question. So talk to me about the journey of
financing and where the product is being used today. Absolutely.
The journey is long and very,
16:40
full of support, you know, like that's, that's a very upfront, you
know, support from my very early days where my MBA classmates kind
of joined force on this project, you know, as in its infancy, the
UCLA, which, you know, venture accelerator, which was my, you know,
first founder, basically, we, we came out of the incubator,
equipped to talk to the world about our business case. And we
got
17:09
$33,000 overnight from the business plan competition, NAP business
plan competition, and the early UCLA founders who just showing
overwhelming support. And we, in fact, we sold our product, first
25 units of our, you know, the digital otoscope in the early days
before we graduated and gotten our first 100K of investor check
before we graduated. So,
17:39
That was when we had to fund the company because we need to find a
place to park the money as students part-time. So this was all
full-time working, you know, professionals part-time on a weekend
going to MBA. And then I, the past just went really interesting
because of the pandemic. There was an overwhelming uptake of
virtual care.
18:07
telehealth services, institutions who are looking at this new
modality of care. And all of a sudden it was like, there were like
800 telehealth companies in the US at some point and they were all
of our potential customers. We started co-calling them and we're
getting quite a bit of feedback. In fact, many of them were working
today. We are working with Rocket Doctor, for example. They've
gotten, they've taken over half a million costs in the past couple
of years.
18:35
in terms of virtual care services. They have sites at pharmacies
and enabled stations of remote care for people who are not
accessing an office in person. We are working with five school
districts in five different states and these are school districts
which leverage Remy for all of their nursing rooms and introducing
it to their students and parents. And we are working
19:05
So we got very strong non-dilutive funding. Actually early days we
had seed funding from Platinum Play, we have seed funding from
United Healthcare Accelerator powered by Techstars. We had in-kind
support from CTIP, which is consortium for technology and
innovation in pediatrics, which is a large innovation, hospital
innovation consortia of, I would say that's growing, you know,
19:34
at least children's hospitals in the West and Midwest. They are
providing enormous support, including clinical collaborations,
partnerships, granting services, regulatory guardrail, they're
FDA-funded. So now we're working with them in terms of a clinical
study site in Lowery Children's in Chicago, which is one of our
primary sites
20:04
testing out not only REMI, Otoscopes, but REMI-AI, funded by the
NIH, which is National Institute of Health under the Small Business
Innovation and Research Grant at 3.5 million so far. So overall,
there was overwhelming support also from my state, I'm from
Washington. So the Life Science Institute of Washington also kind
of invested. And last but not least,
20:32
I have to mention TIE, T-I-E, which is an angel funding investor
group that has given us enormous support in terms of networking, in
terms of fine tuning the business plans, mentorship sessions. It
just goes on. There are a few other investors that we've been
working with and overall we've raised about...
20:56
4.75 million in non-delutive funding, non-delutive, and then about
another a million in the deletive. So this has gone into a clinical
study phase where we're looking at success outcomes in terms of
technology readiness, validation of performance of AI clearance
through FDA as a class two device in a couple of years. And then
commercially.
21:22
being able to facilitate telehealth services already. In addition
to allowing the patients to see and examine, we're enabling
physicians remotely examine and prescribe. And in the future,
assisting both the physician and the patients in terms of
prescription and receiving the accurate diagnosis. I'm looking at
the, heading the all, I guess,
21:52
health care or the goals of health care today, the five aims, I
believe, at least, you know, cutting costs, improving quality,
increasing access. Yeah, all of that. Amazing. And as of today, so
you've raised about 4.75 non dilutive, you're no longer raising
dilutive funding until you get through the clinical trials. When
will that be happening?
22:22
The study with Children's Hospital, Lurie Children's is happening
now actually, so it's underway. And we are looking at in a year
that we will have some tangible, really good results in terms of
both the patient satisfaction, physicians demand and performance of
the technology.
22:50
And what is the desired outcome? Because I got really excited too,
because this will be maybe not the first, but one of the earliest
FDA approved Class II devices jointly with AI, correct?
23:08
Yes, that's a very hot topic right now in terms of the use of AI,
the governance of AI, who benefits from it and who pays for it.
Ultimately, the AI that we are developing would be augmenting the
physician's decision making.
23:33
in the meantime, directly benefiting the patients because they can
potentially receive pre-screening alerts and results faster and
earlier before they go or even while they're waiting for the
physician's appointments. So I would say that the outcome, first
and foremost, is the satisfaction of the patient and the
physicians. We would like to work alongside with, you know,
really
24:00
key influencer in the medical field, medically validating the
performance and understanding the bias of the data. What would it
be if we manipulate bias at one way or the other in terms of the
algorithm development, right? Whether or not we're collecting
comprehensive population-based data, have we looked at cases of
24:28
one way or the other, you know, like in general, understanding the
algorithm development and the AI readout. I think there's a lot of
misunderstanding about AI these days, right? People generalize it
to be generative. But AI has been a concept that is, you know, it
was a different name back then. It was data analysis, it was
imaging analysis, it was big data. For a while, the algorithm is
evolving, the capability is evolving.
24:57
Um, the, I guess before one investor was asking me, what, how do
you handle data hallucination or AI hallucination, which basically
means the AI is starting to give out fake results, um, based on
ungrounded, um, facts or cheating or lying to you. Um, and there's
also another different kind of AI, which was data driven or
validated. Uh, it won't tell you anything that you don't tell
it.
25:27
to, you know, it's kind of limited or confined to a set of
outcomes. For us, it is the former at this point, it's less
generative. We understand the ins and outs of the data that's going
in and we know why it's, you know, spinning out the results while
we are the other on the outcome, on the output side. I would say
generative has got a lot of potential, but within health,
healthcare, we just need to catch up a lot.
25:56
a lot faster for it to be widely applicable. Currently, is it fair
to say that Remy does have the largest database of imaging within
ENT?
26:11
We are one of the top in the world. The data size as the use case
grows, as the user base grows would be growing. The data are
aggregating and being applicable to algorithm training in an
aggregation basis or the identified anonymized.
26:39
It's an interesting part about the platform we're building is the
users can benefit and they know what their, they benefit early, you
know, rather than just being, benefiting from AI telling them what
to do or assisting them. They're benefiting from non-AI
capabilities of the technology, facilitating their visits,
shortening their distance from their pain to a prescription, for
example, or diagnosis.
27:09
already, early on. So we sort of de-risk the path to AI. And AI
becomes more of a later phase. But it is definitely going to
augment and assist the human journey all in all. Excellent. And so
while sticking with the actual platform, and one of the third
elements that I was particularly interested in when
27:37
we did invest from the Thai fund was the lack of the shortage of
primary care physicians, and specifically even pediatricians in the
United States at this time. Talk to me a bit about how as the tech,
that platform of Remy builds out, will this enable doctors will it
substitute doctors? What's the what's the how will this address
this?
28:06
actually, it's tsunami that is now on us of this shortage of
doctors in such a common disease area. Yeah, yeah. I definitely
think that it is a tsunami coming at us just from my experience of
having to book out. My wild child checkup is like four months out.
I was like, by the time I get my son's appointment for his 11 years
old checkup, he's 12. Yeah, so just to give you.
28:36
idea and then I got a letter from my in the mail saying that I'm
quitting, you know, my physician is quitting real life, right. So I
basically think that the AI will be enabling the physicians to free
up their time, you know, from some non acute or issues that they so
in the meantime, providing the quality of care that patients need
not to sacrifice the quality.
29:06
to free up their time and become more efficient in a way.
Especially I can think about ER avoidance, right? As a big use case
for Remy and referral pre-screening, right? Specialty referral
pre-screening, both of those, you know, are gonna free up quite a
bit of our, you know, healthcare resources in terms of leaving them
for those acute cases and really needing, you know, attention of
the physicians. Yeah.
29:35
ER avoidance, basically you go, before you go to the ER, while
you're waiting in the ER, you can perform a test or some sort of a
visit with Remy using the Remy technology and specialties per
screening. Per screening could be like, while you're waiting for
the specialist appointments, which might be three, four months out,
you can get the insights that you need already. So both use cases,
I think, will free up quite a bit of our time.
30:04
both from pediatricians, nurses, mid-level providers, and
specialists, EV doctors and specialists. Oh, Remy. Can you, for my
listeners, talk about where they can find Remy today?
30:22
Yeah, we are, we're in, on Amazon, if you search Remy, we are
website, remyhouse.com. We have a very convenient e-commerce,
shipping and handling protocols. So you should be able to order on
Friday, receive on Monday, for example, or even faster than that.
And then we are, we are at your clinic. We're maybe at your clinic,
maybe at your school district, we are working with a few of
these.
30:52
physicians, clinics, there are logos on our website. If you're one
of the patients of the clinics, you will get these at a discount,
easily accessible rate. And if you visit us at the exhibits, in
terms of commercial and marketing exposures, we are gonna be at
Medica in Germany. That is next week, November 11th to 14th.
31:20
in Dusseldorf in Germany, we are part of the Washington State
Pavilion to exhibit there. And then we are publishing, you know,
academically we are collaborating with United, sorry, University of
Southern California, USC in the speech and speech hearing and
language pathologist community, especially in collaboration with
USC.
31:50
We are publishing a poster there that's going to be December 5 to 7
in Seattle, Washington. Excellent. Let's switch to the founder
sandbox. I'm passionate about working with company owners on their
purpose, their scalability and their resilience. And I have a
founder here in the sandbox with me today.
32:18
You're into what your sixth year of being a CEO. Tell me, what does
resilience mean to you? Jane.
32:31
Oh my gosh, there are so many places you just have to hold on to.
Hold on to the idea. I think first and foremost, it's something
that you believe. There is some belief that this is there. You
know, like it's worth your time. It's worth the effort. It's worth.
Keep going. Right. So if you give up, it's it's probably you don't
believe in it enough. Right. At some point, because of, you know,
all the failures and problems that comes up.
33:02
Yeah, don't get me started. And then the belief is there. I think
this is the future, the calling. It's historically inevitable,
right? If it's Remy or someone else, it should be done, right? So
that's my belief. And it's driven me every day when I wake up. And
then when I think about resilience, I also think about when I'm
fundraising, talking to investors, I get...
33:31
99% knows, right? And then 1%, yes. But does that mean that I'm not
a good company, a good founder? No, it just means we're not good
fit, right? Like investors have their own thesis, their goals to
fill, their speed, stage of company, check sizes, everything has to
meet perfectly. And even personality wise, those investors are
gonna be with you for a while. You trust each other.
34:00
So that's fundraising. And then just keep going at it. And product
wise, people say no to my product. Oftentimes for various reasons,
customers are always right. Again, does that mean that I'm not a
good product or services? No, the more I talk to them, the more nos
I get, the more yes I will get as well. So again, that's sort of on
the market research or understanding the general
34:30
target, you know, like as you're looking for the product market
fit, you know, again, the keyword here is fit. And then the third
piece is, is just just interpersonal, you know, like, people,
oftentimes, I mean, like or dislike each other for a reason. And
there's nothing wrong with, you know, knowing
34:56
knowing more getting more so I have a very big mentor mentor
community I reach out to them every time I need an answer and
they're just all willing to help that really helps with the
mentality the the resilience as well you know I know I'm being
supported I know I know people love me like my products are being
loved my services are needed and my mentors really support me so
that's that's what really helps with the positivity yeah excellent
thank you for those four nuggets
35:26
your own words about what resilience means to you. Thank you for
talking about your product and believing in the future of
telehealth with Remy or not. It's very, very humble. And I loved,
so the key word is fit, right? Fit with your investor, fit with
your customers, what they're wanting, fit with the belief. Take
that to the next.
35:55
question, fit or purpose driven? Are you fit for purpose? What is
purpose driven enterprise? All right, so this this goes beyond the
resilience to enterprise. Purpose driven, what's that mean to
you?
36:09
I think I started the journey caring about sort of mental house of
women, you know, that's like, you know, besides children's health,
health, right. So, and I spent my whole journey, whole research
doing underserved community health diagnostics, right. So I've been
working on, you know, the
36:36
the worst diseases you can think about HIV, tuberculosis, these
pathology pathogens, right? I was kind of in a class three bio lab,
working while I was pregnant, tuberculosis. So you name it, right?
Like any sort of crazy things that happen to people, I have really
strong sort of desire to
37:05
help them or address it. Also something that's probably rooted in
my family. You know, like I don't talk about that a whole lot, but
my dad came out of sort of this pure poverty, right? Like he, my
grandpa was a shepherd and he sort of, I guess long story short, my
dad was also kind of a, would be a beneficiary of Remy. He had a
perforated eardrum because he listened to
37:34
English radios too much before he came to UK for study, you know,
as a first generation college student from his family. So nowadays
he still has a deaf ear, right, like perforated eardrums. So I'm
still thinking, you know, is there something I can do for him? But
overall, I felt as a, like, just to echo where I started in the
beginning, you know, as a woman in the prime years of, you know,
career.
38:04
you know, where I wanted to be, you know, I was earning good money,
I was having a good corporate job, I was caring for my child, you
know, which really kind of pampered my productivity at work. I
think that's kind of an issue that nobody really talks about
because everybody wants top performers, you know, like you need to
be working when your child is sick or something like that. But, you
know, overall, it's kind of
38:30
issue that's there and near to my heart as women and children's
health, especially for underserved communities. Thank you. Thank
you, Jane.
38:41
Wow. Scalable growth. Take that resilience plus your purposefulness
and scale it. Is it truly what the platform will become scalable?
What does scalable mean to you?
39:11
how, you know, help the physicians in a way. You will, I will scale
really well if I can, you know, bring benefits to ease their work,
ease their stress at work. There are patients coming in, they're
getting text messages from the patient, hey, what's going on with
me if I can see this image? I was like, that's crazy. Like, how do
you respond to that, right? Like in a way that polite and shows
that you're a human, you care, but if you get 300 of those a day,
how do you...
39:40
How do you do that? And then they say, oh, they send them to my
charts. Again, that's losing or like the patient just waiting. How
do you address this mismatch of having physicians providing care at
top quality and efficiency while being a human to the patients and
then the patients are satisfied and getting the needs met. I'm
trying to make my story.
40:10
or resonating with physicians that they can be, just to give you an
example, right? A physician mentioned that 50% of my, this was a
specialist who said 50% of the patients who came to me should not
have been in my office because I wanted to help those who can, they
need me for a procedure most of the time. If they come to me for
diagnostics confirmation, I could have done that.
40:40
with their information gathered in front of me already, before they
come. So that's kind of the point. And it's almost like whenever
they're open or free, aggregating physicians time across all these
physicians who have time, whenever they have time to care for
patients aggregated across all these issues, whenever they have an
issue, we're trying to build sort of a bridge
41:11
the aggregation would really help address the problem of mismatch
of asynchronous visits or waiting and not getting the answers. I
don't know if that's too abstract. No, I get it. And you know what?
Kind of along the lines of purpose, your purpose, caring about
mental health for mothers, you also by the adoption of Remy Health
in settings with the patients using it from home.
41:41
or being screened early on, you're clearly affecting the mental
health of our caregivers, our physicians. And we do know that
tsunamis here, there's a high level of attrition. Doctors actually
just quitting. And if through tech enabled or AI powered,
intelligent aggregation of data informs the decisions to reduce
number of visits.
42:10
or have them more productive while in the setting, the clinical
setting can move the needle, so be it. So thank you, Jane. This has
been absolutely an amazing interview. I have one last question. Did
you have fun in the sandbox today? Yes.
42:33
Absolutely, Randa. I really, really appreciate the opportunity.
It's wonderful to every time I talk to you, it's wonderful, but
especially interesting when we're like in this setting and you
know, podcasting to more to a greater audience and really
appreciate what you do for the community. Thank you. Thank you. So
to my listeners, if you'd like this episode with Jane Tseng, CEO of
Remy,
43:03
resilience and scalable and purpose-driven life story, as well as
the origin story, as well as the product. Remy, sign up for the
monthly release where founders and business owners, corporate
directors and professional service providers provide their own
stories on how to build with strong governance, a resilient,
scalable and purpose-driven company to make profits for good.
43:32
Sign off for this month. Thank you for joining us.